Electromedical & Electrotherapeutic Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Electromedical & Electrotherapeutic Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-12-06 | VAR | Varian Medical Systems Inc | Toth Christopher A. | SVP, Pres Oncology Systems | S - Sale | $138.95 | -564 | 1,685 | -25% | -$78,366 | ||||||
2019-12-06 | VRAY | Viewray, Inc. | Strong Influence Ltd | 10% | P - Purchase | $3.13 | +5,750,798 | 19,408,222 | +42% | +$17,999,998 | ||||||
2019-12-06 | VRAY | Viewray, Inc. | Fosun International Ltd | 10% | P - Purchase | $3.13 | +7,348,242 | 23,819,500 | +45% | +$22,999,997 | ||||||
| D | 2019-12-06 | MASI | Masimo Corp | Fitch Sanford | Dir | S - Sale+OE | $156.27 | -7,000 | 44,245 | -14% | -$1,093,913 | |||||
| D | 2019-12-06 | NTUS | Natus Medical Inc | Kennedy Jonathan | Pres, CEO | S - Sale+OE | $31.54 | -6,684 | 141,757 | -5% | -$210,813 | |||||
2019-12-06 | MDT | Medtronic Plc | Anderson Richard H | Dir | P - Purchase | $113.29 | +5,000 | 102,536 | +5% | +$566,450 | ||||||
| DM | 2019-12-04 | BLFS | Biolife Solutions Inc | De Greef Roderick | CFO | S - Sale+OE | $16.14 | -30,000 | 25,859 | -54% | -$484,100 | |||||
| M | 2019-12-04 | RSLSD | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $5.18 | +1,929 | 382,194 | +1% | +$9,997 | |||||
| D | 2019-12-04 | CNMD | Conmed Corp | Kennedy John Jed | VP GM CET | S - Sale+OE | $115.03 | -11,354 | 4,497 | -72% | -$1,306,051 | |||||
2019-12-02 | LIVN | Livanova Plc | McDonald Damien | CEO | S - Sale | $83.71 | -1,000 | 66,016 | -1% | -$83,710 | ||||||
2019-12-03 | SMLR | Semler Scientific, Inc. | Pan Wayne T | Dir | S - Sale | $42.22 | -2,500 | 6,141 | -29% | -$105,548 | ||||||
2019-12-02 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.62 | -34,028 | 3,633,805 | -1% | -$55,125 | ||||||
| D | 2019-12-02 | MDT | Medtronic Plc | White Robert John | EVP, Pres MITG | S - Sale+OE | $110.62 | -52,166 | 52,068 | -50% | -$5,770,829 | |||||
| DM | 2019-11-26 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $16.37 | -7,500 | 17,384 | -30% | -$122,800 | |||||
| M | 2019-11-26 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.55 | -18,069 | 3,667,833 | 0% | -$27,949 | |||||
2019-11-26 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $5.43 | +2,000 | 378,336 | +1% | +$10,860 | ||||||
2019-11-22 | ECOR | Electrocore, Inc. | Tullis James L L | Dir | P - Purchase | $1.43 | +4,984 | 327,339 | +2% | +$7,127 | ||||||
2019-11-22 | BSGM | Biosig Technologies, Inc. | Pease Martha | Dir | P - Purchase | $6.25 | +1,300 | 6,437 | +25% | +$8,125 | ||||||
2019-11-22 | LIVN | Livanova Plc | Moore Daniel Jeffrey | Dir | S - Sale | $80.00 | -3,000 | 30,938 | -9% | -$240,000 | ||||||
| M | 2019-11-21 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.55 | -61,671 | 3,685,902 | -2% | -$95,738 | |||||
2019-11-20 | DRAD | Digirad Corp | Cannell Capital LLC | 10% | S - Sale | $3.19 | -20,293 | 202,826 | -9% | -$64,666 | ||||||
| M | 2019-11-19 | BSGM | Biosig Technologies, Inc. | Pease Martha | Dir | P - Purchase | $6.22 | +3,000 | 5,137 | +140% | +$18,650 | |||||
| M | 2019-11-20 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $5.31 | +2,795 | 374,336 | +1% | +$14,852 | |||||
| D | 2019-11-20 | MASI | Masimo Corp | Sampath Anand | EVP, Ops, Clinical Research | S - Sale+OE | $155.00 | -15,000 | 12,518 | -55% | -$2,325,002 | |||||
| DM | 2019-11-19 | MASI | Masimo Corp | Lee Yongsam | EVP, CIO | S - Sale+OE | $154.76 | -12,500 | 73,000 | -15% | -$1,934,497 | |||||
| M | 2019-11-19 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | P - Purchase | $15.41 | +40,000 | 2,468,571 | +2% | +$616,536 | |||||
| M | 2019-11-18 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.55 | -41,629 | 3,747,573 | -1% | -$64,525 | |||||
2019-11-19 | SLNO | Soleno Therapeutics Inc | Melincoff Gwen A | Dir | P - Purchase | $1.54 | +10,000 | 10,000 | New | +$15,364 | ||||||
| D | 2019-11-15 | VAR | Varian Medical Systems Inc | Kennedy Kolleen T | Pres Proton Solutions, CGO | S - Sale+OE | $128.00 | -4,969 | 27,118 | -15% | -$636,032 | |||||
| D | 2019-11-15 | VAR | Varian Medical Systems Inc | Kuo John W | SVP, GC, Secretary | S - Sale+OE | $128.02 | -465 | 35,103 | -1% | -$59,531 | |||||
2019-11-18 | BSGM | Biosig Technologies, Inc. | Navarro Samuel E | Dir | P - Purchase | $6.46 | +1,000 | 3,500 | +40% | +$6,460 | ||||||
| M | 2019-11-15 | BSGM | Biosig Technologies, Inc. | Pease Martha | Dir | P - Purchase | $6.56 | +1,137 | 2,137 | +114% | +$7,461 | |||||
2019-11-18 | IRIX | Iridex Corp | Grove Robert Earle | Dir | P - Purchase | $2.04 | +14,600 | 52,827 | +38% | +$29,749 | ||||||
| D | 2019-11-18 | MASI | Masimo Corp | Muhsin Bilal | COO | S - Sale+OE | $150.00 | -3,000 | 0 | -100% | -$450,000 | |||||
| M | 2019-11-14 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $6.78 | +3,735 | 368,746 | +1% | +$25,307 | |||||
| D | 2019-11-15 | MDT | Medtronic Plc | Coyle Michael J | EVP, Group Pres, Cardiac, Vasc | S - Sale+OE | $111.25 | -36,874 | 192,616 | -16% | -$4,102,092 | |||||
2019-11-15 | IRIX | Iridex Corp | Grove Robert Earle | Dir | P - Purchase | $2.02 | +10,000 | 38,227 | +35% | +$20,187 | ||||||
| M | 2019-11-13 | IRIX | Iridex Corp | Shuda Scott | Dir | P - Purchase | $2.02 | +15,000 | 36,204 | +71% | +$30,250 | |||||
2019-11-15 | BSGM | Biosig Technologies, Inc. | Pease Martha | Dir | P - Purchase | $6.81 | +1,000 | 1,000 | New | +$6,810 | ||||||
| M | 2019-11-13 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.55 | -97,024 | 3,789,202 | -2% | -$150,387 | |||||
| D | 2019-11-14 | MDT | Medtronic Plc | Coyle Michael J | EVP, Group Pres, Cardiac, Vasc | S - Sale+OE | $109.77 | -2,102 | 192,616 | -1% | -$230,731 | |||||
| D | 2019-11-14 | BLFS | Biolife Solutions Inc | Berard Todd | VP Marketing | S - Sale+OE | $14.06 | -3,000 | 41,074 | -7% | -$42,180 | |||||
| DM | 2019-11-12 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $15.44 | -7,500 | 17,384 | -30% | -$115,800 | |||||
| DM | 2019-11-12 | BLFS | Biolife Solutions Inc | Rice Michael | Pres, CEO | S - Sale+OE | $15.38 | -20,000 | 175,014 | -10% | -$307,600 | |||||
| M | 2019-11-11 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $0.05 | +400,636 | 361,276 | -1018% | +$20,611 | |||||
2019-11-11 | TMDX | Transmedics Group, Inc. | Weill David | Dir | P - Purchase | $17.00 | +10,000 | 10,000 | New | +$170,000 | ||||||
| DM | 2019-11-06 | BLFS | Biolife Solutions Inc | De Greef Roderick | CFO | S - Sale+OE | $17.11 | -30,000 | 25,859 | -54% | -$513,300 | |||||
| A | 2019-11-06 | BSGM | Biosig Technologies, Inc. | Chaussy Steve | CFO | P - Purchase | $6.79 | +2,000 | 597,830 | 0% | +$13,570 | |||||
| A | 2019-11-05 | BSGM | Biosig Technologies, Inc. | Chaussy Steve | CFO | P - Purchase | $6.54 | +3,500 | 595,830 | +1% | +$22,905 | |||||
2019-11-07 | BSGM | Biosig Technologies, Inc. | Navarro Samuel E | Dir | P - Purchase | $6.99 | +2,500 | 2,500 | New | +$17,475 | ||||||
2019-11-05 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.55 | -8,764 | 3,886,226 | 0% | -$13,584 | ||||||
| D | 2019-11-06 | CNMD | Conmed Corp | Shagory Peter K | EVP, STRAT, CORP DEVT | S - Sale+OE | $109.34 | -1,820 | 1,649 | -52% | -$198,999 | |||||
| DM | 2019-11-04 | NTUS | Natus Medical Inc | Kennedy Jonathan | Pres, CEO | S - Sale+OE | $33.98 | -8,676 | 140,841 | -6% | -$294,807 | |||||
| D | 2019-11-01 | LIVN | Livanova Plc | McDonald Damien | CEO | S - Sale+OE | $74.40 | -1,000 | 67,016 | -1% | -$74,400 | |||||
| D | 2019-11-04 | MASI | Masimo Corp | Fitch Sanford | Dir | S - Sale+OE | $147.08 | -6,500 | 44,245 | -13% | -$956,023 | |||||
| D | 2019-11-01 | MDT | Medtronic Plc | White Robert John | EVP, Pres MITG | S - Sale+OE | $109.33 | -52,165 | 52,068 | -50% | -$5,702,995 | |||||
| D | 2019-11-01 | MDT | Medtronic Plc | Coyle Michael J | EVP, Group Pres, Cardiac, Vasc | S - Sale+OE | $109.50 | -38,976 | 192,616 | -17% | -$4,267,872 | |||||
| M | 2019-10-31 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.57 | -334,417 | 3,894,990 | -8% | -$524,787 | |||||
| D | 2019-10-30 | NTUS | Natus Medical Inc | Chung Dong Chune Christopher | VP of Medical Affairs | S - Sale+OE | $33.57 | -14,000 | 150,898 | -8% | -$469,980 | |||||
| D | 2019-10-30 | BLFS | Biolife Solutions Inc | Hinson Andrew G | Dir | S - Sale+OE | $17.87 | -6,000 | 14,461 | -29% | -$107,220 | |||||
| DM | 2019-10-29 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $17.21 | -7,500 | 17,384 | -30% | -$129,100 | |||||
2019-10-25 | SLNO | Soleno Therapeutics Inc | Sinclair Andrew | Dir | P - Purchase | $1.20 | +2,300,000 | 6,969,272 | +49% | +$2,760,000 | ||||||
2019-10-25 | SLNO | Soleno Therapeutics Inc | Abingworth LLP | 10% | P - Purchase | $1.20 | +2,300,000 | 6,969,272 | +49% | +$2,760,000 | ||||||
| M | 2019-10-24 | SLNO | Soleno Therapeutics Inc | Vivo Ventures V, LLC | 10% | S - Sale | $1.59 | -30,547 | 4,229,407 | -1% | -$48,514 | |||||
| DM | 2019-10-15 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $16.18 | -7,500 | 20,077 | -27% | -$121,350 | |||||
| D | 2019-10-15 | BLFS | Biolife Solutions Inc | Berard Todd | VP, Marketing | S - Sale+OE | $16.06 | -3,000 | 41,074 | -7% | -$48,180 | |||||
| DM | 2019-10-15 | BLFS | Biolife Solutions Inc | Rice Michael | Pres, CEO | S - Sale+OE | $16.09 | -20,000 | 175,014 | -10% | -$321,900 | |||||
| D | 2019-10-15 | VAR | Varian Medical Systems Inc | Kuo John W | SVP, GC, Secretary | S - Sale+OE | $113.83 | -465 | 35,101 | -1% | -$52,932 | |||||
| M | 2019-10-04 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $12.38 | -104,450 | 14,227,550 | -1% | -$1,293,520 | |||||
| DM | 2019-10-02 | BLFS | Biolife Solutions Inc | De Greef Roderick | CFO | S - Sale+OE | $15.71 | -30,000 | 25,859 | -54% | -$471,300 | |||||
| DM | 2019-10-01 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $16.15 | -7,500 | 17,384 | -30% | -$121,150 | |||||
| M | 2019-10-02 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $11.47 | -68,740 | 14,332,000 | 0% | -$788,435 | |||||
2019-10-01 | LIVN | Livanova Plc | McDonald Damien | CEO | S - Sale | $73.82 | -1,000 | 59,774 | -2% | -$73,820 | ||||||
2019-09-30 | BLFS | Biolife Solutions Inc | Hinson Andrew G | Dir | S - Sale | $16.01 | -6,000 | 9,747 | -38% | -$96,060 | ||||||
| D | 2019-10-01 | MASI | Masimo Corp | Fitch Sanford | Dir | S - Sale+OE | $149.43 | -6,500 | 44,245 | -13% | -$971,266 | |||||
2019-09-27 | MDT | Medtronic Plc | Kuntz Richard | SVP, Chief Medical, Science | S - Sale | $107.51 | -21,425 | 78,816 | -21% | -$2,303,493 | ||||||
2019-09-27 | NDRA | Endra Life Sciences Inc. | Wells David R. | CFO | P - Purchase | $1.18 | +10,000 | 44,786 | +29% | +$11,800 | ||||||
| DM | 2019-09-17 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $20.64 | -7,500 | 17,384 | -30% | -$154,800 | |||||
2019-09-17 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $0.05 | +396,072 | 29,000,000 | +1% | +$19,804 | ||||||
| DM | 2019-09-17 | BLFS | Biolife Solutions Inc | Schick Joseph C | Dir | S - Sale+OE | $21.00 | -5,000 | 6,875 | -42% | -$105,000 | |||||
| D | 2019-09-16 | BLFS | Biolife Solutions Inc | Berard Todd | VP, Marketing | S - Sale+OE | $20.02 | -3,000 | 41,074 | -7% | -$60,060 | |||||
| D | 2019-09-16 | VAR | Varian Medical Systems Inc | Kuo John W | SVP, GC, Secretary | S - Sale+OE | $116.30 | -465 | 35,101 | -1% | -$54,080 | |||||
2019-09-16 | LIVN | Livanova Plc | Moore Daniel Jeffrey | Dir | S - Sale | $84.56 | -1,500 | 33,938 | -4% | -$126,845 | ||||||
| D | 2019-09-16 | MASI | Masimo Corp | Young Micah W | EVP, CFO | S - Sale+OE | $150.02 | -12,087 | 0 | -100% | -$1,813,291 | |||||
| D | 2019-09-10 | MDT | Medtronic Plc | Hakami Hooman | EVP, Group Pres Diabetes | S - Sale+OE | $107.31 | -82,877 | 30,761 | -73% | -$8,893,712 | |||||
| D | 2019-09-10 | DRAD | Digirad Corp | Eberwein Jeffrey E. | Dir | P - Purchase | $10.00 | +300,000 | 1,585,092 | +23% | +$3,000,000 | |||||
| DM | 2019-09-09 | BLFS | Biolife Solutions Inc | Rice Michael | Pres, CEO | S - Sale+OE | $19.39 | -28,571 | 175,014 | -14% | -$554,115 | |||||
| DM | 2019-09-04 | BLFS | Biolife Solutions Inc | De Greef Roderick | CFO | S - Sale+OE | $19.78 | -30,000 | 25,859 | -54% | -$593,300 | |||||
| DM | 2019-09-03 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $20.07 | -7,500 | 17,384 | -30% | -$150,525 | |||||
2019-09-03 | LIVN | Livanova Plc | McDonald Damien | CEO | S - Sale | $77.00 | -1,000 | 60,774 | -2% | -$77,000 | ||||||
| D | 2019-09-03 | VRAY | Viewray, Inc. | Dempsey James F. | Chief Scientific Officer | S - Sale+OE | $3.57 | -279,414 | 220,973 | -56% | -$996,390 | |||||
2019-08-30 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $0.07 | +53,928 | 28,207,856 | 0% | +$3,775 | ||||||
2019-08-30 | BLFS | Biolife Solutions Inc | Hinson Andrew G | Dir | S - Sale | $20.07 | -6,000 | 15,747 | -28% | -$120,420 | ||||||
| M | 2019-08-27 | RSLS | Reshape Lifesciences Inc. | Armistice Capital, LLC | 10% | P - Purchase | $0.07 | +200,000 | 111,705,000 | 0% | +$14,000 | |||||
2019-08-27 | CNMD | Conmed Corp | Peters Stanley W III | VP GM Advanced Surgery | S - Sale | $101.76 | -500 | 130 | -79% | -$50,880 | ||||||
| M | 2019-08-22 | NDRA | Endra Life Sciences Inc. | Wells David R. | CFO | P - Purchase | $1.55 | +10,000 | 34,786 | +40% | +$15,550 | |||||
2019-08-22 | MASI | Masimo Corp | Fitch Sanford | Dir | S - Sale | $150.39 | -7,000 | 44,245 | -14% | -$1,052,730 | ||||||
| DM | 2019-08-20 | BLFS | Biolife Solutions Inc | Mathers James | VP, Global Sales | S - Sale+OE | $20.45 | -7,500 | 17,384 | -30% | -$153,375 | |||||
2019-08-19 | LIVN | Livanova Plc | Moore Daniel Jeffrey | Dir | S - Sale | $80.25 | -1,500 | 35,438 | -4% | -$120,375 | ||||||
| D | 2019-08-20 | EYES | Second Sight Medical Products Inc | McGuire Jonathan Will | CEO | S - Sale+OE | $0.81 | -3,902 | 142,770 | -3% | -$3,151 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |